Review of the morphological and immunohistochemical aspects of diffuse large B cell lymphoma (DLBCL) with emphasis on the mouth
DOI:
https://doi.org/10.5335/rfo.v24i2.10459Keywords:
Mouth, Lymphoma, Diffuse large Bcell lymphoma, Non-Hodgkin lymphomaAbstract
Lymphomas comprise a diverse group of malignant neoplasias from cells of the immune system at different stages of differentiation. Objective: this article aimed to facilitate the diagnosis of diffuse large B-cell lymphoma (DLBCL) through its clinical, morphological, and immunohistochemical aspects, as well as its particularities as a primary manifestation in the mouth. Literature Review: hence, a narrative review of the literature was performed using articles selected in the PubMed, Medline, SciELO, and Lilacs databases through keyword search. Aspects related to classification and clinical manifestations were also considered to facilitate the understanding of the lesion and its particularities in the mouth. It was verified that the diffuse large B-cell lymphoma (DLBCL) represents the most common variant in the mouth. The clinical signs and symptoms related to this condition may be increased volume, pain, ulceration, changed mucosal color, or even paresthesia. Morphologically, DLBCL presents large cells with diffuse growth pattern, scarce cytoplasm, evident nucleoli, and mitoses. In immunohistochemistry, DLBCL is usually positive for CD20 and other markers of lineage B (CD19, CD79a, PAX5, and CD138) depending on the maturation stage in which B cells are found. Final considerations: the diagnosis of oral DLBCL represents a continuous challenge for pathologists due to the heterogeneity of its morphological and immunophenotypic characteristics.
Downloads
References
2. Tomioka H, Kaneoya A, Mochizuki Y, Harada H. Primary diffuse large B-cell lymphoma arising in the tongue accompanied by ataxia-telangiectasia: A case report. Journal of Clinical & Diagnostic Research 2015; 9(6):25-7.
3. Swerdlow SH, Campo E, Pilleri SA, Harris NL, Stein H, Siebert R, et al. The Updated Who Classification of Hematological Malignancies. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Journal Blood 2016; 127(20):2391-405.
4. Gurbaxani S, Anastasi J, Hyjek E. Diffuse large B-cell lymphoma-more than a diffuse collection of large B cells. An entity in search of a meaningful classification. Archives of Pathology & Laboratory Medicine 2009; 133(7): 1121-34.
5. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Journal Blood 2011; 117(19):5019-32.
6. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SAP, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4. ed. Lyon, France: IARC Press; 2008.
7. Guilherme RS, Caputto LZ, Fonseca ALA, Pereira J, Fonseca FLA. Exames laboratoriais complementares indicados no apoio ao diagnóstico do linfoma difuso de grandes células B (LDGCB). Arquivos Brasileiros de Ciências da Saúde 2008; 33(3):185-94.
8. Montes-Moreno S, Odqvist L, Diaz-Perez JA, Lopez M, Villambrosia SG, Mazorra F, et al. EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive postgerminal center B-cell neoplasm characterized by prominent nuclear factor-KB activation. Modern Pathology 2012; 25(7):968-82.
9. Sirsath NT, Lakshmaiah KC, Das U, Lokanatha D, Chennagiri SP, Ramarao C. Primary extranodal non-Hodgkin’s lymphoma of oral cavity- a single centre retrospective study. Journal of Cancer Research and Therapeutics 2014; 10(4):945-50.
10. Bishop JA, Westra WH. Plasmablastic lymphoma involving the parotid gland. Head and Neck Pathology 2011; 4(2):148-51.
11. Basquiera A, Márquez M, Vijnovich A, Picon A, Zerga, M. Linfoma difuso de células B [internet]. Sociedade Argentina de Hematologia. Guia de tratamento em espanhol 2015 [acesso em 10 jul. 2017]. Disponível em URL: http://www. sah.org.ar/docs/251- 274.5B.SAH_GUIA2012_LinfomaCelulasGrandes_1.pdf.
12. Owosho AIA, Bilodeau EA, Surti U, Craig FEF. Large B-cell lymphoma of the tongue and oral cavity: a practical approach to identifying prognostically importante subtypes. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2014; 118(3):338-47.
13. Santos PSS, Ferreira ES, Vidote RM, Paes RAP, Freitas RR. Manifestação bucal de linfoma difuso de grandes células B. Rev Brasil Hematologia e Hemoterapia 2009; 31(6):473-47;6.
14. Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA. Hematopathology. Philadelphia: Elsevier; 2011.
15. Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma a population based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 92(5):519-25.
16. Georgakopoulou EA, Achtari MD, Evangelou K, Kittas C. Oral non-Hodgkin’s lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate. J Clin Exp Dent 2015; 7(1):180-2.
17. Zen Filho EV, Tinoco-Araujo JE, da Silva-Santos OS, Coracin FL. Linfomas - manifestações orais e maxilofaciais. Prática Hospitalar 2011; 78:32-7.
18. Souto GR, Pereira TSF, Castro AF, Mesquita RA. Diffusive large B-cell lymphoma, not otherwise especified of the palate: a case report. J Clin Exp Dent 2013; 5(5):287-90.
19. Said JW. Aggressive B-cell lymphomas: How many categories do we need? Modern Pathology 2013; 26(1):42-56.
20. O’Connell FP, Pinkus JL, Pinkus GS. CD 138 (Syndecan-1), a plasma cell marker. Immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am Society for Clinical Pathology 2004; 121(2):254-63.
21. Velez I, Hogge M. Primary Maxillofacial large B-cell lymphoma in immunocompetent patients: report of 5 cases. Case Reports in Radiology 2011; 2011:108023. DOI: 10.1155/2011/108023.
22. Bugshan A, Kassolis J, Basile J. Primary diffusive large B-cell lymphoma of the mandible: case report and review of the literature. Case Reports in Oncology 2015; 8(3):451-5.
Downloads
Published
Issue
Section
License
This work is licensed under aCreative Commons Atribuição-NãoComercial-SemDerivações 4.0 Internacional.
